Evaluation and treatment of pump thrombosis and hemolysis.

Authors

• Vakhtang Tchantchaleishvili
• Fabio Sagebin
• Ronald E Ross
• William Hallinan
• Karl Q Schwarz
• H Todd Massey

Publication/Presentation Date

9-1-2014

Abstract

Ventricular assist devices (VADs) are not fully biocompatible, and are therefore predisposed to device thrombosis and subsequent pump dysfunction. Clinically significant hemolysis in VADs most often occurs as a result of device thrombosis, but can also be caused by other factors. Herein we describe the evaluation and management of VAD thrombosis and hemolysis.

Volume

3

Issue

5

First Page

490

Last Page

495

ISSN

2225-319X

Published In/Presented At

Tchantchaleishvili, V., Sagebin, F., Ross, R. E., Hallinan, W., Schwarz, K. Q., & Massey, H. T. (2014). Evaluation and treatment of pump thrombosis and hemolysis. Annals of cardiothoracic surgery, 3(5), 490–495. https://doi.org/10.3978/j.issn.2225-319X.2014.09.01

Disciplines

Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods

PubMedID

25452909

Department(s)

Administration and Leadership

Document Type

Article